Press release

Press release

October 21, 2019

Follicum successfully completes toxicology studies for upcoming FOL-005 Phase IIa clinical trial in patients with hair loss

Follicum today announces that the company has successfully completed the supplementary toxicology studies that will form the basis of the forthcoming clinical study with the topical formulation of FOL-005. The company expects to be ready for the start of the clinical study in patients with hairloss (alopecia) in early 2020. Preparations for the clinical trial […]

September 26, 2019

Follicum initiates collaboration with Bioglan for the production of FOL-005 cream for upcoming clinical trial on patients with hair loss

Lund, Sweden, September 26. Follicum today announces the signing of a cooperation agreement with Bioglan AB for the production of clinical trial material of Follicum’s new, cream-like formulation of FOL-005 for topical treatment. The formulation will be used in the Phase II clinical trial on hair loss, which is expected to start in the beginning […]

September 17, 2019

Follicum AB receives Notice of Allowance from the U.S. Patent Office for method of stimulating hair growth with FOL-005

Follicum AB (“Follicum”) announces that the U.S. Patent Office (USPTO) has issued a Notice of Allowance for their patent application 16/176,201 which when granted confers expanded protection for Follicum’s product candidate FOL-005. Follicum has already two granted US patents in this patent family (US 9,381,149 and US 10,137,169), conferring protection for different forms of FOL-005. […]

July 11, 2019

Follicum receives approval of patent in Korea

Follicum AB (”Follicum”) today announces that the Korean patent office (”KIPO”) has approved the company’s patent application for stimulation of hair growth. With the approval in Korea, patent number 10-1992282, Follicum has a patent protection in Korean up to and including year 2032. The patent protects the company’s peptides in general and for stimulation of […]

June 17, 2019

Successful meeting with the German Medicines Agency regarding preparations for topical phase II scalp study

Follicum AB (“Follicum” or “company”) today report that the company has had a successful scientific advisory meeting regarding the hair project FOL-005, with the German authority, BfArM. In accordance with the previously announced timetable, Follicum has prepared a background document for scientific advice with the German Medicinces agency BfArM. The meeting discussed which additional toxicity […]

June 13, 2019

Follicum receives LUDC post-doc funding for novel diabetes peptide mode of action research

Follicum AB (“Follicum” or “The Company”), a biotechnology company developing new peptide drugs in two areas, hair loss and diabetes, reports today that Dr. Chrysostomi Gialeli has been recruited to a full-time postdoctoral position for 2 years to further investigate the function and mechanism of action of Follicum’s various peptides. The Postdoc position is 100% […]

June 10, 2019

Follicum strengthens its clinical expertise in diabetes as novel peptide candidate approaches clinic – establishes Scientific Advisory Board

Follicum AB today announces the establishment of a Scientific Advisory Board in the diabetes field. The purpose is to strengthen knowledge transfer from academic research to clinical application and commercialization. The Board consists of 5 internationally reputable experts with extensive experience in research into diabetes and its complications. – By setting up a Scientific Advisory […]

May 8, 2019

Follicum receives patent grant in Europe – broadened protection for lead candidate FOL-005

Follicum has received an official grant of patent from the European Patent Office, EPO regarding the company’s broadened patent application for stimulation of hair growth. The official grant follows the “Intention to Grant” which was communicated on November 21, 2018. With EPO’s grant of patent no. EP 3087999 B1, there is now broad protection for […]

April 29, 2019

Follicum files patent application for new topical formulation of FOL-005 for hair loss

Using easy-to-apply cream instead of direct scalp injection would extend patent protection by 8 years Follicum AB (“Follicum” or “the company”) today announced that the company’s hair loss treatment projects are progressing according to plan and a patent application for an internally developed formulation of FOL-005 has been submitted. The cream formulation is intended to […]

February 11, 2019

Follicum selects novel peptide drug candidate for the treatment of diabetes and protection of beta cells

Follicum AB (“Follicum” or “the company”), a biotech company focusing on research and development of peptide-based drugs, today reports that a drug candidate has been selected for the treatment of diabetes and protection of beta cells. The drug candidate has shown unique effects in both in vitro and in vivo-models, including diabetes-related complications. The drug […]